PTGX
NASDAQ · Biotechnology
Protagonist Therapeutics Inc
$115.03
+2.17 (+1.92%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+29.57%
1Y
+115.57%
YTD
+31.95%
Open$113.24
Previous Close$112.86
Day High$116.57
Day Low$113.24
52W High$114.49
52W Low$49.38
Volume—
Avg Volume743.5K
Market Cap7.26B
P/E Ratio—
EPS$-1.80
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$85.10
Above
SMA 200
$67.75
Above
RSI (14)
58.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
-73.5% upside
Current
$115.03
$115.03
Target
$30.47
$30.47
$24.78
$30.47 avg
$49.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 46.55M | 38.77M | 743.95M |
| Net Income | -131,658,232 | -98,686,107 | -91,860,800 |
| Profit Margin | -282.8% | -268.7% | -12.4% |
| EBITDA | -158,669,007 | -125,539,732 | -161,541,358 |
| Free Cash Flow | — | — | -86,698,990 |
| Rev Growth | +20.1% | +20.1% | +6.6% |
| Debt/Equity | — | — | 0.40 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |